1. Home
  2. ICG vs TTRX Comparison

ICG vs TTRX Comparison

Compare ICG & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intchains Group Limited

ICG

Intchains Group Limited

HOLD

Current Price

$1.85

Market Cap

97.1M

Sector

Technology

ML Signal

HOLD

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$4.70

Market Cap

92.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ICG
TTRX
Founded
2017
2015
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.1M
92.5M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
ICG
TTRX
Price
$1.85
$4.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$7.50
$8.00
AVG Volume (30 Days)
121.5K
75.3K
Earning Date
11-13-2025
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
94.43
N/A
EPS
0.21
N/A
Revenue
$36,367,850.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$75.98
N/A
P/E Ratio
$8.40
N/A
Revenue Growth
6.53
N/A
52 Week Low
$0.93
$2.57
52 Week High
$7.95
$26.50

Technical Indicators

Market Signals
Indicator
ICG
TTRX
Relative Strength Index (RSI) 53.55 N/A
Support Level $1.76 N/A
Resistance Level $2.10 N/A
Average True Range (ATR) 0.17 0.00
MACD -0.01 0.00
Stochastic Oscillator 50.00 0.00

Price Performance

Historical Comparison
ICG
TTRX

About ICG Intchains Group Limited

Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology company focused on developing pharmaceutical and medical device products for dermatology, wound care, and infectious disease. The company's proprietary platform technology, called PermaFusion, enhances drug performance by improving the stability and bioavailability of active pharmaceutical ingredients, which allows for reduced doses and fewer side effects. Its primary development programs target skin conditions such as moderate to severe eczema and onychomycosis.

Share on Social Networks: